Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · IEX Real-Time Price · USD
7.59
-0.27 (-3.44%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Voyager Therapeutics Market Cap
Voyager Therapeutics has a market cap or net worth of $412.85 million as of July 2, 2024. Its market cap has decreased by -19.77% in one year.
Market Cap
412.85M
Enterprise Value
13.28M
1-Year Change
-19.77%
Ranking
Category
Stock Price
$7.59
Market Cap Chart
Since November 11, 2015, Voyager Therapeutics's market cap has decreased from $456.60M to $412.85M, a decrease of -9.58%. That is a compound annual growth rate of -1.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 412.80M | 11.18% |
| Dec 29, 2023 | 371.30M | 57.66% |
| Dec 30, 2022 | 235.50M | 128.86% |
| Dec 31, 2021 | 102.90M | -61.59% |
| Dec 31, 2020 | 267.90M | -48.20% |
| Dec 31, 2019 | 517.20M | 69.02% |
| Dec 31, 2018 | 306.00M | -31.60% |
| Dec 29, 2017 | 447.40M | 31.43% |
| Dec 30, 2016 | 340.40M | -41.89% |
| Dec 31, 2015 | 585.80M | 28.30% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avid Bioservices | 425.31M |
| Verve Therapeutics | 419.83M |
| Alector | 418.31M |
| EyePoint Pharmaceuticals | 417.20M |
| Ocugen | 414.34M |
| Heron Therapeutics | 412.79M |
| Treace Medical Concepts | 411.11M |
| Acelyrin | 407.99M |